Trials / Conditions / Glucocorticoid-induced Osteoporosis
Glucocorticoid-induced Osteoporosis
5 registered clinical trials studyying Glucocorticoid-induced Osteoporosis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteo NCT06588153 | Amgen | Phase 4 |
| Unknown | Efficacy and Safety of JMT103 in the Treatment of Glucocorticoid Induced Osteoporosis NCT05397938 | Shanghai JMT-Bio Inc. | Phase 2 |
| Completed | Romosozumab Versus Denosumab for Osteoporosis in Long-term Glucocorticoid Users NCT04091243 | Tuen Mun Hospital | Phase 4 |
| Withdrawn | Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders NCT02418273 | Indiana University | Phase 1 / Phase 2 |
| Completed | Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis NCT03164928 | Amgen | Phase 3 |